Aerosol therapy in the equine species

[en] Inhalation therapy plays an increasing role in the management of equine respiratory disorders. This alternative to systematic treatment permits a high concentration of medication to act locally while minimizing side effects and residues. In human medicine, literature in this field is prolific and continuously renewed, whereas in veterinary medicine, applications of aerosol therapy are less extensive. This review considers the principles of action of the different types of devices used for inhalation, i.e., nebulization, metered-dose inhalation and dry powder inhalation, describes the technical and practical requirements for their use in the equine species and considers the advantages and disadvantages of each inhalation device. The pharmacological agents currently administered to horses by inhalation are also discussed. Perspectives of aerosol therapy in the equine species, including aerosols already used in human medicine and their potential applications for horses are described

Disciplines :

Anatomy (cytology, histology, embryology...) & physiology
Veterinary medicine & animal health

Author, co-author :

Duvivier, Dominique Hannia

Votion, Dominique ; Université de Liège - ULiège > Département clinique des animaux de compagnie et des équidés > Anesthésiologie gén. et pathologie chirurg. des grds animaux

Vandenput, Sandrina ; Université de Liège - ULiège > CARE "Le Réseau des bibliothèques" > Bibliothèque des Sciences de la vie

Lekeux, Pierre ; Université de Liège - ULiège > Département de sciences fonctionnelles > Physiologie

Language :

English

Title :

Aerosol therapy in the equine species

Publication date :

1997

Journal title :

Veterinary Journal

ISSN :

1090-0233

eISSN :

1532-2971

Publisher :

Elsevier

Volume :

154

Issue :

Pages :

189-202

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 07 April 2009

Statistics

Number of views

69 (6 by ULiège)

Number of downloads

5 (3 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

ADJEI, A. (1993a). Pulmonary bioavailability of LH-RH analogs: a case study with leuprolide and other LH-RH analogs. In Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung, ed. G. C. Smaldone, New York: Mary Ann Liebert, Inc. Publishers, 6 (Suppl.), pp. 54.
ADJEI, A. (1993b). Pulmonary bioavailability of leuprolide following multiple dosing to beagle dogs: some pharmacokinetic and preclinical issues. In Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung, ed. G. C. Smaldone, New York: Mary Ann Liebert, Inc. Publishers, 6 (Suppl.), pp. 54.
AGNER, J. E. (1984). Physical properties and mechanisms of deposition of aerosols. In Aerosols and the Lung: Clinical and Experimental Aspects, Clarke S. W., Pavia D., London: Butterworth and Co, pp. 49-70.
ALABASTER, V. A. & MOORE, B. A. (1993). Drug intervention in asthma: present and future. Thorax 48, 176-82.
ATKINS, P. J., BARKER, N. P., MATHISEN, D. (1992). The design and development of inhalation drug delivery systems. In Pharmaceutical Inhalation Aerosol Technology, ed. Hickey, A. J., pp. 155-185. New York: Marcel Dekker Inc.
BARGER, G. & DALE, H. H. (1910). Chemical structure and sympathomimetic action of amines. Journal of Physiology 41, 19-59.
BARNES, P. J. & PEDERSEN, S. (1993). Efficacy and safety of inhaled corticosteroids in asthma. American Review of Respiratory Disease 148, S1-S26.
BARNES, P. J. (1995). Molecular mechanisms of anti-asthma therapy. Annals of Medicine 27 (5), 531-35.
BARTON, A. D. (1974). Aerosolized detergents and mucolytic agents in the treatment of stable chronic obstructive pulmonary disease. American Review of Respiratory Disease 110, 104-10.
BAUER, R., BANHOLZER, R. (1993). Pharmacology of quaternary anticholinergic drugs. In Anticholinergic Therapy in Obstructive Airway Disease, ed. Gross, N. J., pp. 105-115. London: Franklin Scientific Publications.
BEASLEY, C. R. W., RAFFERTY, P. & HOLGATE, S. T. (1987). Bronchoconstrictor properties of preservatives in ipratropium bromide (Atrovent). nebulizer solution. British Medical Journal 294, 1197-8.
BEECH, J. (1991). Chronic obstructive pulmonary disease. Veterinary Clinics of North America: Equine Practice 7 (1), 79-91.
BELVISI, M. G., STRETTON, C. D., MIURA, M., VERLEDEN, G. M., TAJKARIMI, S., YACOUB, M. H. & BARNES, P. J. (1992). Inhibitory NANC nerves in human tracheal smooth muscle: a quest for the neurotransmitter. Journal of Applied Physiology 73, 2505-10.
BERTI, F., ROSSONI, G., ROBUSCHI, M. & MANDELLI, V. (1995). Protective effect of fluroxemide combined with non-steroidal anti-inflammatory drugs administered by inhalation route on guinea-pigs anaphylaxis model. Drug Research 45-2: 10, 1098-102.
BIANCO, S., VAGHI, A., ROBUSHI, M. & PASARGIKLIAN, M. (1988). Prevention of exercise-induced bronchoconstriction by inhaled frusemide. Lancet 2, 252- .
BIANCO, S., PIERONI, M. G., REFINI, R. M., ROTTOLI, L. & SESTINI, P. (1989). Protective effects of inhaled furosemide on allergen-induced early and late asthmatic reactions. New England Journal of Medicine 321, 1069- .
BOHADANA, A. B., PESLIN, R., TECULESCU, D., POLU, J. M., BELVILLE, F. & MASSIN, N. (1980). The bronchodilator action of theophylline aerosol in subjects with chronic airflow obstruction. Bulletin Européen de Physiopathologie Respiratoire 16, 13-24.
BRACHER, V., VON FELLENBERG, R., WINDER, C. N., GUENIG, G. & HERMANN, M. (1991). An investigation of the incidence of chronic obstructive pulmonary disease (COPD). in random populations of Swiss horses. Equine Veterinary Journal 23 (2), 136-41.
BRAIN, J. D. & VALBERG, P. A. (1979). Deposition of aerosol in the respiratory tract. American Review of Respiratory Disease 20, 1325-67.
BRAIN, J. D., VALBERG, P. A., SNEDDON, S. (1985). Mechanisms of aerosol deposition and clearance. In Aerosols in Medicine: Principles, Diagnosis and Therapy, ed. Dolovich, M. B., chapter 5, pp123, 47. Oxford: Elsevier Science Publishers.
BRIDGES, P. A., TAYLOR, K. M. G., MCCALLION, O. N. M. (1995). Nebulisation of liposomes - The effects of formulation variables. In Proceedings Drug Delivery to the Lungs VI, pp. 81-84, London: The Aerosol Society.
BROADSTONE, R. V., ROBINSON, N. E., GRAY, P. R., WOODS, P. S. A. & DERKSEN, F. J. (1991). Effect of furosemide on ponies with recurrent airway obstruction. Pulmonary Pharmacology 4, 203-8.
BROADSTONE, R. V., LEBIANC, P. H., DERKSEN, F. J. & ROBINSON, N. E. (1991). In vitro responses of airway smooth muscle from horses with recurrent airway obstruction. Pulmonary Pharmacology 4, 191-202.
CHAROENPAN, P., KIATBOONSRI, S., USWANOPAKHUN, P., VONGVIVAT, K. & SULAIMANEE, P. (1990). The effects of inhaled ipratropium bromide, fenoterol and their combination in COPD patients. Journal of Medicine Association of Thail & 73, 91-5.
CHRISTOFORIDIS, A. J., TOMASHEFSKI, J. F. & MITCHELL, R. I. (1971). Use of an ultrasonic nebulizer for the application of oropharyngeal, laryngeal and tracheo-bronchial anaesthesia. Chest 59, 629-33.
CLARK, T. J. H. (1982). Safety of inhaled corticosteroids. European Journal of Respiratory Disease 63, (Suppl. 122), 235-42.
CLARKE, S. W. & NEWMAN, S. P. (1984). Therapeutic aerosols 2 - drugs available by the inhaled route. Thorax 39, 1-7.
CLARKE, S. W., PAVIA, D. (1988). Defense mechanisms and immunology, deposition and clearance. In Textbook of Respiratory Medicine, ed. Nadel, J. A., Philadelphia: W.B. Saunders Co, pp. 313.
CLARKE, A. F. (1991). Practicalities of nebulization. Equine Veterinary Education 3 (1), 45-9.
CLAY, M. M., PAVIA, D., NEWMAN, S. P. & CLARKE, S. W. (1983a). Factors influencing the size distribution of aerosols from jet nebulizers. Thorax 38, 755-9.
CLAY, M. M., PAVIA, D., NEWMAN, S. P., LENNARD-JONES, T. & CLARKE, S. W. (1983b). Assessment of jet nebulizers for lung aerosol therapy. Lancet 2, 592-4.
COX, J. S. G. (1969). Disodium cromoglycate in asthma. British Medical Journal 3, 177- .
CUSHLEY, M. J. & HOLGATE, S. T. (1983). Efficacy of inhaled methyl xanthines as bronchodilators in asthma. Thorax 38, 223- .
DERKSEN, F. J., ROBINSON, N. E., ARMSTRONG, P. J., STICK, J. A. & SLOCOMBE, R. F. (1985). Airway reactivity in ponies with recurrent airway obstruction (heaves). Journal of Applied Physiology 58, 598-604.
DERKSEN, F. J., ROBINSON, N. E. & BERNEY, C. E. (1992). Aerosol pirbuterol: bronchodilator activity and side effects in ponies with recurrent airway obstruction (heaves). Equine Veterinary Journal 24, 107-12.
DERKSEN, F. J. (1993). Chronic obstructive pulmonary disease (heaves), as an inflammatory condition. Equine Veterinary Journal 25, 257-8.
DERKSEN, F. J. (1995). Use of bronchodilator therapy in the horse. In Proceedings Swiss Vet, 4° Congrès de Médecine et Chirurgie Equine de Genève 11-S, 106-7.
DERKSEN, F. J., OLSZEWSKI, M., ROBINSON, N. E., BERNEY, C., LLOYD, J. W., HAKALA, J., MATSON, C. & RUTH, D. (1996). Use of a hand-held, metered-dose aerosol delivery device to administer pirbuterol acetate to horses with 'heaves'. Equine Veterinary Journal 28, 306-10.
DISSE, B., REICHL, R., SPECK, G., TRAUNECKER, W., ROMINGER, K. L. & HAMMER, R. (1993). Ba679Br, a novel long-acting anticholinergic bronchodilator. Life Sciences 52, 537-44.
DIXON, P. M. (1992). Therapeutics of the respiratory tract. In Current Therapy in Equine Medicine 3, ed. Robinson N. E., pp. 303-10. Philadelphia: W.B. Saunders Company.
DIXON, P. M., RAILTON, D. I. & MCGORUM, B. C. (1995). Equine pulmonary disease: a case control of 300 referred cases. Part 1: examination techniques, diagnostic criteria and diagnoses. Equine Veterinary Journal 27, 416-21.
DUCHARME, G. & FUBINI, S. L. (1983). Gastrointestinal complications associated with the use of atropine in horses. Journal of the American Veterinary Medical Association 182, 229-31.
DUVIVIER, D. H., ART, T., VANDENPUT S., VOTION, D., LEKEUX, P. (1986). Bronchodilating effects of inhaled dry powder ipratropium bromide in COPD horses: a dose finding study. In Proceedings of the 14th Comparative Respiratory Society Meeting, Orlando, USA, P51.
FLAMENT, M. P., LETERME, P. & GAYOT, A. T. (1995). Factors influencing nebulizing efficiency. Drug Development and Industrial Pharmacy 21, 2263-85.
GENICOT, B., MOULIGNEAU, F. & LEKEUX, P. (1992). L'aérosolthérapie: principes d'action et exigences techniques pour des résultats thérapeutiques optimaux. Annales de Médecine Vétérinaire 136, 81-7.
GEOR, R. J. (1995). Performance-limiting conditions of the lungs. In The Horse. Diseases and Clinical Management, Vol. 1., Kobluk, C. N., Ames, T. R., Geor, R. J., pp. 263-73. Philadelphia: W.B. Saunders Company.
GREENOUGH, A., YUKSEL, B., EVERETT, L. & PRICE, J. F. (1993). Inhaled ipratropium bromide and terbutaline in asthmatic children. Respiratory Medicine 87, 111-4.
GROSS, N. J. & SKORODIN, M. S. (1984). Anticholinergic, antimuscarinic bronchodilators. American Review of Respiratory Disease 129, 856-70.
IKEDA, A., NISHIMURA, K., KOYAMA, H. & IZUMI, T. (1995). Bronchodilating effects of combined therapy with clinical dosages of ipratropium bromide and salbutamol for stable COPD: comparison with ipratropium bromide alone. Chest 107, 401-5.
JAFFE, H. A., BUHL, R., MASTRANGELI, A., HOLROYD, K. J., SALTINI, C., CZERSKI, D., JAFFE, H. S., KRAMER, S., SHERWIN, S. & CRYSTAL, R. G. (1991). Organ specific cytokine therapy. Local activation of mononuclear phagocytes by delivery of an aerosol of recombinant interferon-gamma to the human lung. Journal of Clinical Investigation 88, 297-302.
KAMADA, A. K. (1994). Therapeutic controversies in the treatment of asthma. Annals of Pharmacotherapy 28, 904-14.
KLEIN, J.-J., DEEGAN, E. (1985). Non-specific airway hyperreactivity in horses and the influence of corticosteroids. In Lung Function and Respiratory Diseases in the Horse, ed. Deegen, E., Beadle, R. E., pp. 61-4. Calw: Hippiatrika-Verlagsgesellschaft.
KNOWLES, M. R. (1993). Recent advances in aerosol therapy. In Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung, ed. Smaldone, G. C. New York: Mary Ann Liebert, Inc. Publishers, 6 (Suppl.), 13.
KÖHLER, D. (1993). Aerosolized heparin. In Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung, ed. Smaldone, G. C. New York: Mary Ann Liebert, Inc. Publishers, 6 (Suppl.), 108.
KÖNIG, P. (1984). Inhaled corticosteroids: use and abuse? Allergy Proceeding 5, 37-8.
KÖNIG, P. (1985). Spacer devices used with metered-dose inhalers: breakthrough or gimmick? Chest 88, 276-84.
LAPOINTE, J.M., LAVOIE, J-P. & VRINS, A. (1993). Effects of triamcinolone acetonide on pulmonary function and bronchoalveolar lavage cytologic features in horses with chronic obstructive pulmonary disease. American Journal of Veterinary Research 58, 1310-6.
LEKEUX, P., CLERCX, C., ART, T. (1993). Functional effects of obstructive pulmonary diseases. In Pulmonary function in healthy, exercising and diseased animals.ed. Lekeux, P., pp. 229-66. Gent: VI Dierg. Tijdschr.
LEONG, K. H. (1992). Theoretical principles and devices used to generate aerosols for research. In Pharmaceutical Inhalation Aerosol Technology, ed. Hickey, A. J., 129-54. New York: Marcel Dekker Inc.
LIPWORTH, B. J. (1993). Clinical pharmacology of corticosteroids in bronchial asthma. Pharmacology and Therapeutics 58, 173-209.
LITTLEWOOD, J. M., SMYE, S. W. & CUNLIFFE, H. (1993). Aerosol antibiotic treatment in cystic fibrosis. Archives of Disease in Childhood 68, 788-92.
LÖFDAHL, C. G. & CHUNG, K. F. (1991). Long-acting adrenoceptor agonists: a new prospective in the treatment of asthma. European Respiratory Journal 4, 218-26.
MAESEN, F. P. V., SMEETS, J. J., SLEDSENS, T. J. H., WALD, F. D. M. & CORNELISSEN, P. J. G. on behalf of a Dutch Study Group. (1995). Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). European Respiratory Journal 8, 1506-13.
MAJUMDAR, S. P. & KUMAR, T. R. (1994). Inhalation steroids, some aspects and ways in the management of asthma. Journal of the Indian Medical Association 92, 233-4.
MANN, J. S., HOWARTH, P. H. & HOLGATE, S. T. (1984). Bronchoconstriction induced by ipratropium bromide in asthma: relation to hypotonicity. British Medical Journal 289, 469- .
MCBRIDE, J. T. (1990). Study design considerations for ribavirin: efficacy studies. Paediatric Infectious Disease Journal 9, S74-8.
MCKIERNAN, B. C., KORITZ, G. D., SCOTT, J., BERNEY, C. & ROBINSON, N. E. (1992). Plasma theophylline concentration and lung function in ponies with recurrent obstructive lung disease. Equine Veterinary Journal 3, 194-7.
MERCER, T. T. (1981). Production of therapeutic aerosols: principles and techniques. Chest 80, 813-7.
MOREN, F. (1985). Aerosol dosage forms and formulations. In Aerosols in Medicine, Principles, Diagnosis and Therapy, ed. Moren, F., Newhouse, M. T., Dolovich, M. B., pp. 260, 87. Oxford: Elsevier Science Publishers, chapter 10.
MORRIS, H. G. (1987). An update in treatment of asthma with inhaled steroids. Allergy Proceeding 8, 85-94.
MORROW, P. E. (1986). Factors determining hygroscopic aerosol deposition in airways. Physiological Reviews 66, 330-76.
MURPHY, J. L., MCPHERSON, E. A. & DIXON, P. M. (1980). Chronic obstructive pulmonary disease (COPD): effects of bronchodilator drugs on normal and affected horses. Equine Veterinary Journal 12, 10-14.
NEWMAN, M. T. & DOLOVICH, M. B. (1986). Current concepts: control of asthma by aerosol. New England Journal of Medicine 315, 870-4.
NEWMAN, S. P. (1985). Aerosol deposition considerations in inhalation therapy. Chest 88 (Suppl. 2), 152S-160S.
O'DRISCOLL, B. R. C. & COCHRANE, G. M. (1987). Emergency use of nebulized bronchodilator drugs in British hospitals. Thorax 42, 491-3.
OLSON, L. E., PERKOWSKI, S. Z., MASON, D. E. & MUIR, W. W. (1989). Isoproterenol- and salbutamol-induced relaxation of acetylcholine- and histamine-induced contraction of equine trachealis muscle in vitro. American Journal of Veterinary Research 50, 1715-9.
PAKES, G. E., BROGDEN, R. N., HEEL, R. C., SPEIGHT, T. M. & AVERY, G. S. (1980). Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs 20, 237-66.
PATERSON, J. W. & SHENFIELD, G. M. (1974). Bronchodilators. Thorax and Tuberculosis Association Review 4, 25-74.
PATERSON, J. W., WOOLCOCK, A. J. & SHENFIELD, G. M. (1979). Bronchodilator drugs. American Review of Respiratory Disease 120, 1149-88.
PAVIA, D., THOMSON, M. L., CLARKE, S. W. & SHANNON, H. S. (1977). Effect of lung function and mode of inhalation on penetration of aerosol into the human lung. Thorax 32, 194-7.
PAVIA, D., BATEMAN, J. R. M. & CLARKE, S. W. (1980). Deposition and clearance of inhaled particles. Bulletin Européen de Physiopathologie Respiratoire 16, 335-66.
PEARSON, E. G. & RIEBOLD, T. W. (1989). Comparison of bronchodilators in alleviating clinical signs in horses with chronic obstructive pulmonary disease. Journal of the American Veterinary Medical Association 194, 1287-91.
RAABE, O. G. (1976). In "Fine particles". New York: Academic Press, 1976, 57-110.
RADERMECKER, M. (1987). L'aérosolthérapie. Revue Médicale de Liège XLII 10, 433-6.
RIMAR, S. %, GILLIS, C. N. (1992). Pulmonary vasodilation by inhaled nitric oxide after endothelial injury. Journal of Applied Physiology 73 (5), 2179-83.
ROBINSON, N. E., DERKSEN, F. J., BERNEY, C. & GOOSSENS, L. (1993). The airway response of horses with recurrent airway obstruction (heaves), to aerosol administration of ipratropium bromide. Equine Veterinary Journal 25, 299-303.
ROSE, R. J., HODGSON, D. R. (1993). Lower respiratory tract diseases. In Manual of Equine Practice, ed. Rose, R. J. & Hodgson, D. R., pp. 160-9. Philadelphia: W.B. Saunders Company.
RUBIE, S., ROBINSON, N. E., STOLL, M., BROADSTONE, R. V. & DERKSEN, F. J. (1993). Flunixin meglumine blocks frusemide-induced bronchodilatation in horses with chronic obstructive pulmonary disease. Equine Veterinary Journal 25, 138-42.
RUOFF, W. W. (1988). Fungal pneumonias in horses. Proceedings of the American Association of Equine Practitioners 34, 423- .
SCOTT, J. S., BERNEY, C. E., DERKSEN, F. J. & ROBINSON, N. E. (1991). Beta-adrenergic receptor activity in ponies with recurrent obstructive pulmonary disease. American Journal of Veterinary Research 52, 1416-22.
SILVERMAN, M. (1990). Aerosol therapy in the newborn. Archives of Disease in Childhood 65, 906-8.
SIVULA, N. J. (1995). Respiratory diseases of the neonate. In The Horse, Diseases and Clinical Management, Kobluk, C. N., Ames, T. R., Geor, R. J., Vol. 2, pp. 1227-34. Philadelphia: W.B. Saunders Company.
SOMA, L. R., BEECH, J. & GERBER, N. H. (1987). Effects of cromolyn in horses with chronic obstructive pulmonary disease. Veterinary Research Communication 11, 339-51.
STAHLOFEN, W., GEBHART, J. & HEYDER, J. (1980). Experimental determination of the regional deposition of aerosol particles in the human respiratory tract. American Industrial Hygiene Association Journal 41, 385-98.
TABURET, A. M. & SCHMIT, B. (1994). Pharmacokinetic optimization of asthma treatment. Clinical Pharmacokinetic 26, 396-418.
TAYLOR, G., HARRIS, W. & BOGDONOFF, M. (1971). Ventricular arythmias induced in monkeys by the inhalation of aerosol propellants. Journal of Clinical Investigation in Toxicology 50, 1546-50.
TESAROWSKI, D. B., VIEL, L., MCDONELL, W. N. & NEWHOUSE, M. T. (1994). The rapid and effective administration of a b2-agonist to horses with heaves using a compact inhalation device and metered-dose inhalers. Canadian Veterinary Journal 35, 170-3.
TIMSINA, M. P., MARTIN, G. P., MARRIOTT, C., GANDERTON, D. & YIANNESKIS, M. (1994). Drug delivery to the respiratory tract using dry powder inhalers. International Journal of Pharmaceutics 101, 1-13.
THOMSON, J. R. & MCPHERSON, E. A. (1981). Prophylactic effects of sodium cromoglycate on chronic obstructive pulmonary disease in the horse. Equine Veterinary Journal 13, 243-6.
THOMPSON, D. C. (1992). Pharmacology of therapeutic aerosols. In Pharmaceutical Inhalation Aerosol Technology, ed. Hickey, A. J., pp. 29-59. New York: Marcel Dekker Inc.
TOOGOOD, J. H. (1988). Budesonide in children with asthma. European Journal of Clinical Pharmacology 34, 113-4.
TOOGOOD, J. H., JENNINGS, B., BASKERVILLE, J., ANDERSON, J. & JOHANSSON, S. A. & (1984). Dosing regimen of budesonide and occurrence of oropharyngeal complications. European Journal of Respiratory Disease 65, 35-44.
TRANFA, C. M. E., VATRELLA, A., PARELLA, R. & BARIFFI, F. (1995). Effect of ipratropium bromide and/or sodium cromoglycate pretreatment on water-induced bronchoconstriction in asthma. European Respiratory Journal 8, 600-4.
TURGUT, K. & SASSE, H. H. L. (1989). Influence of clenbuterol on mucociliary transport in healthy horses and horses with chronic obstructive pulmonary disease. Veterinary Record 125, 526-30.
VIDGREN, M., KAKKAINEN, A., KARJALAINEN, P., NUUTINEN, J. & PARONEN, P. (1988). In vitro and in vivo deposition of drug particles inhaled from pressurized aerosol and dry powder inhaler. Drug Development and Industrial Pharmacy 14, 2649-65.
VOTION, D., GHAFIR, Y., ART, T. & LEKEUX, P. (1996). Comparison of an ultrasonic and a jet nebulizer for inhalation therapy in horses. In Proceedings of the 14th Comparative Respiratory Society Meeting, Orlando, USA.
WEINER, N. (1980). Atropine, scopolamine and related antimuscarinic drugs. In The Pharmacologic Basis of Therapeutics, eds. Gilman, A. G., Goodman, L. S., Gilman, A., 6th Edn. New York: MacMillan, 135.
WILSON, W. D. (1992). Foal Pneumonia. In Current Therapy in Equine Medicine, ed. Robinson, N. E., pp. 466-73. Philadelphia: W.B. Saunders Company.
WINDOM, H., BURGESS, C.., CRANE, J. & BEASLEY, R. (1990). Airways effects of inhaled chlorbutol is asthmatic subjects. Thorax 45, 345-.
YU, M., WANG, Z., ROBINSON, N. E. & DERKSEN, F. J. (1992). The inhibitory effect of furosemide on the contractile response of equine trachealis to cholinergic nerve stimulation. Pulmonary Pharmacology 5, 233-8.
YU, M., WANG, Z., ROBINSON, N. E. & LEBIANC, P. H. (1994). Inhibitory nerve distribution and mediation of NANC relaxation by nitric oxide in horse airways. Journal of Applied Physiology 76, 339-44.
ZENG, X. M., MARTIN, G. P. & MARRIOTT, C. (1995). Preparation and in vitro evaluation of tetrandrine-entrapped albumin microspheres as an inhaled drug delivery system. European Journal of Pharmaceutical Science 3, 87-95.